Twenty subjects with mild allergic asthma were randomized to receive 7 days of treatment with nebulized AZD5423 ( 75 or 300 g ) once daily , budesonide 200 g twice daily via Turbuhaler , or placebo in a double-blind , four-period , crossover design study .